La marque MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease, fondée en 2013 (États-Unis), a 126 marques sœurs et 17477 marques concurrentes. La marque MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease est détenue par Celgene, société cotée à New York. MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease fait partie du secteur d’activité Fabricants de médicaments.

MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease est une marque de Celgene () Autres marques

Acheter l'action Celgene avec

(0% de commission et fractions d'actions)

Votre capital est assujetti à un risque. D'autres frais s'appliquent. Pour plus d'informations, rendez-vous sur etoro.com/trading/fees.

Autres marques
Celgene

JUNO THERAPEUTICS

A
- APICES
- AMDAC
- ACELAGRAFT
- ANTHROGENESIS
- ACSELA
- ARTIMIDS
- APACT
- ADVANCING IMID SCIENCE
- APR
B
- BIOVANCE
- BECLIPSA
- BODAPRA
C
- COMPROMISO 360
- CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE)
- CELGENE THALIDOMIDE
- C2ARE
- CELGENE i-access
- CELGENECARE
- CANCERCAN
- cintre
- CONTINUUM
- CELG
- CHIMERIC VIGOR
- CELMOD
- CELGENE MULTIPLE MYELOMA RESOURCE CENTER
- CELGENE AVILOMICS RESEARCH
- CELGENE MATRIX
- CYTUNE
- CITRE
- CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE
- CANCER
- CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
D
- DOING WELL BY DOING GOOD
- DIRAZEC
E
- EXPECT
- EGARZO
- EMCRUZO
- ENKEPLO
- EJETSA
- ESTEEM
F
- FIDHIRO
- FOCUSING ON THOSE WHO CAN LEAST AFFORD TO LIVE
- FIRST TRIAL
G
- GLOBAL PSORIASIS SURVEY Navigating the Course of Psoriatic Disease
H
- HUMANIFESTO
I
- IACCESS
- ISELATE
- IMID
- IDHISO
- INREBIC
- IMLINIR
- IMNOVYD
- IMNOVID
- ISTODAX
- IMLINEER
K
- KEXTENA
- KEVOLI
L
- LifebankUSA
M
- MULTIPLE PATHWAYS, MULTIPLE TARGETS
- MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
- MYELOMA ALLY
- MM 013
- MATRIX Medical Affairs Tracking Reporting and Information Xchange
- MATRIX: MEDICAL AFFAIRS TRACKING REPORT AND INFORMATION XCHANGE
- MAINSAIL
- mpact
N
- NIMBUS
O
- ORIGIN
- ORVIMID
- ONUREG
- OKEZLI
- ONCRUZO
- OTEZLA
- OCRUZO
- OGARTEZ
- ORCOMPAS
- OPTIMISMM
- ODAPRA
P
- PEBIOR
- PRIORITY MEDICINE. IN PRACTICE.
- PHARMION
- PURARIT
- POSTURE
- POMALISS
- POMALYST
- PAZNEO
- POMD
- POML
- PALACE
Q
- QUAZAR
R
- REVAID
- RevAssist
- Rev
- Revlimid
- RIMIDRA
- RULOYUS
- RAPVOTI
- ROJUSNA
- REBLOZEL
- ROJUZDA
- RYORLO
- ROBUST
- RELEVANCE
- RELEVANT
- RESUME
S
- sprint
- SECLIPSA
- SOSTEGRA
- S.T.E.P.S.
- SELARREST
- SELATAK
- SUVMIDI
T
- THALIDOMIDE CELGENE
- TURNING CANCER INTO CAN
- TREATMENT CONTINUATION SCHEME
- TCS
- TIME IN A CAPSULE
- THALOMID
- TNACITY
- TIME TO LIVE
- THALIDOMIDE PHARMION
V
- VIPP
- Vidaza
- VOLOMYD